Shandong Weigao Group Medical Polymer Company Limited
Символ: SHWGF
PNK
0.9575
USDПазарна цена днес
15.1964
Съотношение P/E
0.0000
Коефициент PEG
4.33B
MRK Cap
- 0.02%
Доходност на DIV
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4577.73 | 1140.1 | 1157.2 | 1238.3 | |||||
balance-sheet.row.short-term-investments | 252.88 | 48.6 | 71.2 | 68.3 | |||||
balance-sheet.row.net-receivables | 4304.13 | 1134.8 | 1016.6 | 963.4 | |||||
balance-sheet.row.inventory | 1282.22 | 351.7 | 332.8 | 279.5 | |||||
balance-sheet.row.other-current-assets | 282 | 0 | 93.4 | 69.3 | |||||
balance-sheet.row.total-current-assets | 10446.08 | 2626.7 | 2600 | 2550.5 | |||||
balance-sheet.row.property-plant-equipment-net | 4119.75 | 1034 | 1051 | 1055.1 | |||||
balance-sheet.row.goodwill | 2094.91 | 525.5 | 523 | 525.2 | |||||
balance-sheet.row.intangible-assets | 2315.97 | 0 | 770.5 | 807.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 4410.88 | 525.5 | 1293.4 | 1332.6 | |||||
balance-sheet.row.long-term-investments | 1261.12 | 309.5 | 316.4 | 346.4 | |||||
balance-sheet.row.tax-assets | 97.12 | 29.2 | 22.9 | 24.6 | |||||
balance-sheet.row.other-non-current-assets | -1271.38 | 221.4 | -512.8 | -512.8 | |||||
balance-sheet.row.total-non-current-assets | 8617.49 | 2119.5 | 2171 | 2245.9 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 19063.57 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.account-payables | 801.73 | 163.2 | 207.3 | 203.2 | |||||
balance-sheet.row.short-term-debt | 1013.5 | 449 | 182.4 | 150 | |||||
balance-sheet.row.tax-payables | 116.78 | 33.8 | 25.7 | 23.6 | |||||
balance-sheet.row.long-term-debt-total | 1672.52 | 210.8 | 488.3 | 542 | |||||
Deferred Revenue Non Current | 39.58 | 9.8 | 1.1 | 0.5 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 109.99 | - | - | - | |||||
balance-sheet.row.other-current-liab | 1687.06 | 395.7 | 410 | 409.2 | |||||
balance-sheet.row.total-non-current-liabilities | 2008.61 | 295.4 | 538.3 | 668.5 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 56.89 | 14.2 | 15 | 9.1 | |||||
balance-sheet.row.total-liab | 5721.24 | 1364.2 | 1391.3 | 1480.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 261.28 | 64.4 | 65.7 | 71.7 | |||||
balance-sheet.row.retained-earnings | 7396.3 | 0 | 2475.7 | 2381.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 449.87 | 0 | 178.7 | 160.6 | |||||
balance-sheet.row.other-total-stockholders-equity | 4281.46 | 3100 | 394.2 | 430.3 | |||||
balance-sheet.row.total-stockholders-equity | 12388.91 | 3164.5 | 3114.3 | 3044.1 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 19063.57 | 4746.2 | 4771 | 4796.4 | |||||
balance-sheet.row.minority-interest | 943.48 | 217.6 | 255.5 | 257.3 | |||||
balance-sheet.row.total-equity | 13332.39 | 3382.1 | 3369.8 | 3301.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 19063.57 | - | - | - | |||||
Total Investments | 1514 | 358.1 | 387.6 | 414.7 | |||||
balance-sheet.row.total-debt | 2742.91 | 674 | 685.6 | 701.1 | |||||
balance-sheet.row.net-debt | -1581.94 | -417.6 | -400.4 | -468.9 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 578.86 | 405.4 | 351.7 | 302.4 | ||||
cash-flows.row.depreciation-and-amortization | 180.87 | 118.9 | 113 | 102.2 | ||||
cash-flows.row.deferred-income-tax | 0 | -469.7 | -381.9 | -294.9 | ||||
cash-flows.row.stock-based-compensation | 0 | 91.8 | 76.5 | 30.7 | ||||
cash-flows.row.change-in-working-capital | 0 | -158.8 | -38.1 | -30.3 | ||||
cash-flows.row.account-receivables | 0 | -124.1 | -40.2 | -106.1 | ||||
cash-flows.row.inventory | 0 | -80.2 | -27.9 | -37.9 | ||||
cash-flows.row.account-payables | 0 | 64.1 | -11.2 | 84.1 | ||||
cash-flows.row.other-working-capital | 0 | -18.6 | 41.3 | 29.6 | ||||
cash-flows.row.other-non-cash-items | 79.47 | 341 | 337.5 | 281.5 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 477.47 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.acquisitions-net | 0 | 4.9 | 219.6 | -19.6 | ||||
cash-flows.row.purchases-of-investments | 0 | -247.2 | -5.9 | -27.6 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.1 | 0.6 | 0.1 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | 0.5 | 216.9 | ||||
cash-flows.row.net-cash-used-for-investing-activites | -431.95 | -408.3 | 34.6 | 23.8 | ||||
cash-flows.row.debt-repayment | 0 | -13.9 | -30.5 | -151.3 | ||||
cash-flows.row.common-stock-issued | 0 | -35.2 | 40.4 | 37.5 | ||||
cash-flows.row.common-stock-repurchased | 0 | -5.2 | -11.3 | -1.9 | ||||
cash-flows.row.dividends-paid | 0 | -110.4 | -101 | -101.6 | ||||
cash-flows.row.other-financing-activites | 0 | 40.3 | -176.3 | 10.5 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -299.9 | -124.5 | -278.7 | -206.9 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 91.63 | 96.2 | -54.4 | -57 | ||||
cash-flows.row.net-change-in-cash | -162.76 | -84 | 251.7 | 263.1 | ||||
cash-flows.row.cash-at-end-of-period | 3233.28 | 1086 | 1170 | 918.3 | ||||
cash-flows.row.cash-at-beginning-of-period | 3396.05 | 1170 | 918.3 | 655.2 | ||||
cash-flows.row.operating-cash-flow | 477.47 | 328.6 | 458.7 | 391.6 | ||||
cash-flows.row.capital-expenditure | 0 | -166.2 | -180.2 | -146 | ||||
cash-flows.row.free-cash-flow | 477.47 | 162.4 | 278.5 | 245.6 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3898.31 | 1871.6 | 2027.3 | 2041.4 | |||||
income-statement-row.row.cost-of-revenue | 1976.8 | 970.9 | 1005.8 | 942.3 | |||||
income-statement-row.row.gross-profit | 1921.51 | 900.7 | 1021.6 | 1099.1 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 164.76 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.operating-expenses | 1162.01 | 581.1 | 566.3 | 622.9 | |||||
income-statement-row.row.cost-and-expenses | 3138.81 | 1552 | 1572 | 1565.2 | |||||
income-statement-row.row.interest-income | 0 | 33.3 | 26.8 | 22.4 | |||||
income-statement-row.row.interest-expense | 66.8 | 38.6 | 28.5 | 21.7 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 50.32 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 6.6 | 10.3 | 10.9 | |||||
income-statement-row.row.total-operating-expenses | 50.32 | 4.7 | 27.4 | -42.1 | |||||
income-statement-row.row.interest-expense | 66.8 | 38.6 | 28.5 | 21.7 | |||||
income-statement-row.row.depreciation-and-amortization | 246.7 | 128.2 | 118.9 | 113 | |||||
income-statement-row.row.ebitda-caps | 1006.19 | - | - | - | |||||
income-statement-row.row.operating-income | 759.49 | 319.6 | 455.3 | 476.1 | |||||
income-statement-row.row.income-before-tax | 809.81 | 324.3 | 482.7 | 434 | |||||
income-statement-row.row.income-tax-expense | 107.52 | 43.5 | 63.2 | 64.9 | |||||
income-statement-row.row.net-income | 690.09 | 283.2 | 405.4 | 351.7 |
Често задавани въпроси
Какво е Shandong Weigao Group Medical Polymer Company Limited (SHWGF) общи активи?
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) общите активи са 4746213417.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 1870949024.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.070.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.070.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.152.
Какъв е общият приход на предприятието?
Общият приход е 0.168.
Каква е Shandong Weigao Group Medical Polymer Company Limited (SHWGF) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 283215434.000.
Какъв е общият дълг на фирмата?
Общият дълг е 674011810.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 581122121.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 1091566057.000.